Intepirdine (SB-742457; GSK-742457; RVT-101)

Alias: GSK 742457; GSK-742457; RVT-101; SB742457; SB 742457; GSK742457; SB-742457; RVT 101; RVT101
Cat No.:V1020 Purity: ≥98%
Intepirdine (formerly GSK-742457; RVT-101; SB742457; SB 742457; GSK742457; SB-742457; RVT 101) is a potent and highly selective 5-HT6 receptor antagonist with potential cognition, memory, and learning-enhancing effects.
Intepirdine (SB-742457; GSK-742457; RVT-101) Chemical Structure CAS No.: 607742-69-8
Product category: 5-HT Receptor
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
5mg
10mg
25mg
50mg
100mg
500mg
1g
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

Intepirdine (formerly GSK-742457; RVT-101; SB742457; SB 742457; GSK742457; SB-742457; RVT 101) is a potent and highly selective 5-HT6 receptor antagonist with potential cognition, memory, and learning-enhancing effects. It shows >100-fold selectivity for 5-HT6 over other receptors and inhibits 5-HT6 with a pKi of 9.63.

Biological Activity I Assay Protocols (From Reference)
Targets
5-HT6 Receptor ( pKi = 9.63 )
ln Vitro

In vitro activity: SB-742457 is a selective antagonist of the 5-HT6 receptor that improves learning, memory, and cognitive function.[2] SB-742457 is a new Alzheimer's disease cognitive enhancer. Potential medication SB-742457 is added to subjects with mild-to-moderate Alzheimer's disease in order to stabilize their donepezil treatment.[1]

ln Vivo
SB-742457 is a potent and selective 5-HT6 receptor antagonist that has been demonstrated to improve elderly rats' performance in a water maze task and to reverse a learning deficit caused by scopolamine in the novel object recognition test.[1]
Animal Protocol
N/A
N/A
References

[1] Alzheimers Dement, 2006, 2, S631–S632 (abstract).

[2]. Neurotherapeutics . 2008 Jul;5(3):458-69.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C19H19N3O2S
Molecular Weight
353.44
Exact Mass
353.12
Elemental Analysis
C, 64.57; H, 5.42; N, 11.89; O, 9.05; S, 9.07
CAS #
607742-69-8
Related CAS #
607742-69-8
Appearance
Solid powder
SMILES
C1CN(CCN1)C2=CC=CC3=CC(=CN=C32)S(=O)(=O)C4=CC=CC=C4
InChi Key
JJZFWROHYSMCMU-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H19N3O2S/c23-25(24,16-6-2-1-3-7-16)17-13-15-5-4-8-18(19(15)21-14-17)22-11-9-20-10-12-22/h1-8,13-14,20H,9-12H2
Chemical Name
3-(benzenesulfonyl)-8-piperazin-1-ylquinoline
Synonyms
GSK 742457; GSK-742457; RVT-101; SB742457; SB 742457; GSK742457; SB-742457; RVT 101; RVT101
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: 50~78 mg/mL (141.5~220.7 mM)
Water: <1 mg/mL
Ethanol: ~2 mg/mL (~5.7 mM)
Solubility (In Vivo)
Solubility in Formulation 1: ≥ 2.5 mg/mL (7.07 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (7.07 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

View More

Solubility in Formulation 3: 2% DMSO , 48% PEG300, 2% Tween 80 and 48% water: 5mg/mL


 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.8293 mL 14.1467 mL 28.2933 mL
5 mM 0.5659 mL 2.8293 mL 5.6587 mL
10 mM 0.2829 mL 1.4147 mL 2.8293 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02669433 Completed Drug: RVT-101 35 mg
Drug: RVT-101 70 mg
Dementia With Lewy Bodies Axovant Sciences Ltd. January 2016 Phase 2
NCT02585934 Completed Drug: RVT-101
Drug: Placebo
Alzheimer's Disease Axovant Sciences Ltd. October 2015 Phase 3
NCT00710684 Completed Drug: SB-742457 15mg
Drug: SB-742457 35mg
Alzheimer's Disease GlaxoSmithKline July 1, 2008 Phase 2
NCT00708552 Completed Drug: SB-742457
Drug: Placebo
Drug: Donepezil
Alzheimer's Disease GlaxoSmithKline July 4, 2008 Phase 2
NCT00551772 Completed Drug: SB-742457 Alzheimer's Disease GlaxoSmithKline August 2007 Phase 1
Biological Data
  • SB742457
    Effects of the 5-HT2A receptor agonist TCB-2 and the 5-HT7 receptor agonist AS 19 on smooth muscle cell membrane potential in endothelium-intact preparations.Br J Pharmacol. 2011 Oct; 164(3): 979–991.
  • SB742457
    Effects of SB269970, glibenclamide and Rp-cAMPS on 5-HT-induced changes in smooth muscle cell membrane potential in endothelium-intact preparations.Br J Pharmacol. 2011 Oct; 164(3): 979–991.
  • SB742457
    Effects of SB269970 with or without sarpogrelate on 5-HT-induced changes in smooth muscle cell membrane potential in endothelium-denuded preparations.Br J Pharmacol. 2011 Oct; 164(3): 979–991.
Contact Us Back to top